Home/Filings/4/0001415889-23-005596
4//SEC Filing

Sanford Svai S 4

Accession 0001415889-23-005596

CIK 0001856725other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 9:06 PM ET

Size

7.0 KB

Accession

0001415889-23-005596

Insider Transaction Report

Form 4
Period: 2023-03-27
Sanford Svai S
Chief Financial Officer
Transactions
  • Award

    Class A Common Stock

    2023-03-27+139,000258,597 total
  • Award

    Stock Option (Right to Buy)

    2023-03-27+205,800205,800 total
    Exercise: $5.44Exp: 2033-03-26Class A Common Stock (205,800 underlying)
Footnotes (2)
  • [F1]The shares subject to the restricted stock unit grant vest as follows: 1/16th of the RSUs shall vest quarterly over four years from March 27, 2023.
  • [F2]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from March 27, 2023.

Issuer

Rani Therapeutics Holdings, Inc.

CIK 0001856725

Entity typeother

Related Parties

1
  • filerCIK 0001591411

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 9:06 PM ET
Size
7.0 KB